Atlas Trials

Safety and Efficacy of Adalimumab in Patients Who Showed an Unsatisfactory Response to Etanercept

Clinical trial NCT00927069 · COMPLETED

Trial details

NCT number
NCT00927069
Sponsor
Innovaderm Research Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Plaque Psoriasis
Start date
2007-03-01
Primary completion
2008-09-01
Enrollment
85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.